Literature DB >> 17950728

IL-2 withdrawal induces HTLV-1 expression through p38 activation in ATL cell lines.

Miki Washiyama1, Kazuo Nishigaki, Nursarat Ahmed, Syuichi Kinpara, Yuichi Ishii, Noriyuki Kanzawa, Takao Masuda, Mari Kannagi.   

Abstract

Expression of human T-cell leukemia virus type-1 (HTLV-1) in adult T-cell leukemia (ATL) cells is known to be marginal in vivo and inducible in short-term culture. In this study, we demonstrated that withdrawal of interleukin (IL)-2 from IL-2-dependent ATL cell lines resulted in induction of HTLV-1 mRNA and protein expression, and that viral induction was associated with phosphorylation of the stress kinase p38 and its downstream CREB. Pharmacological inhibitors of the p38 pathway suppressed viral expression induced by IL-2 depletion. These results indicate that the stress-induced p38 pathway might up-regulate HTLV-1 gene expression through at least CREB activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950728     DOI: 10.1016/j.febslet.2007.10.008

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease.

Authors:  Unsong Oh; Matthew J McCormick; Dibyadeep Datta; Richard V Turner; Kathryn Bobb; Dileep D Monie; D Robert Sliskovic; Yuetsu Tanaka; Jie Zhang; Jeffrey Meshulam; Steven Jacobson
Journal:  Blood       Date:  2011-01-06       Impact factor: 22.113

Review 2.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

3.  Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon.

Authors:  Shuichi Kinpara; Atsuhiko Hasegawa; Atae Utsunomiya; Hironori Nishitsuji; Hiroyuki Furukawa; Takao Masuda; Mari Kannagi
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

Review 4.  Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.

Authors:  Mari Kannagi; Atsuhiko Hasegawa; Yoshiko Nagano; Shuichi Kimpara; Youko Suehiro
Journal:  Retrovirology       Date:  2019-08-22       Impact factor: 4.602

5.  Histone H2A monoubiquitylation and p38-MAPKs regulate immediate-early gene-like reactivation of latent retrovirus HTLV-1.

Authors:  Anurag Kulkarni; Graham P Taylor; Robert J Klose; Christopher J Schofield; Charles Rm Bangham
Journal:  JCI Insight       Date:  2018-10-18

6.  Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy.

Authors:  Britta Moens; Daniele Decanine; Soraya Maria Menezes; Ricardo Khouri; Gilvanéia Silva-Santos; Giovanni Lopez; Carolina Alvarez; Michael Talledo; Eduardo Gotuzzo; Ramon de Almeida Kruschewsky; Bernardo Galvão-Castro; Anne-Mieke Vandamme; Johan Van Weyenbergh
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24

7.  The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.

Authors:  Ghada Kchour; Rahim Rezaee; Reza Farid; Akram Ghantous; Houshang Rafatpanah; Mahdi Tarhini; Mohamad-Mehdi Kooshyar; Hiba El Hajj; Fadwa Berry; Mohamad Mortada; Roudaina Nasser; Abbas Shirdel; Zeina Dassouki; Mohamad Ezzedine; Hossein Rahimi; Ardeshir Ghavamzadeh; Hugues de Thé; Olivier Hermine; Mahmoud Mahmoudi; Ali Bazarbachi
Journal:  Retrovirology       Date:  2013-08-20       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.